{"title":"Equity considerations in COVID-19 vaccine allocation modelling: a literature review","authors":"Eva Rumpler, Marc Lipsitch","doi":"arxiv-2409.11462","DOIUrl":null,"url":null,"abstract":"We conducted a literature review of COVID-19 vaccine allocation modelling\npapers, specifically looking for publications that considered equity. We found\nthat most models did not take equity into account, with the vast majority of\npublications presenting aggregated results and no results by any subgroup (e.g.\nage, race, geography, etc). We then give examples of how modelling can be\nuseful to answer equity questions, and highlight some of the findings from the\npublications that did. Lastly, we describe seven considerations that seem\nimportant to consider when including equity in future vaccine allocation\nmodels.","PeriodicalId":501172,"journal":{"name":"arXiv - STAT - Applications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - STAT - Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2409.11462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We conducted a literature review of COVID-19 vaccine allocation modelling
papers, specifically looking for publications that considered equity. We found
that most models did not take equity into account, with the vast majority of
publications presenting aggregated results and no results by any subgroup (e.g.
age, race, geography, etc). We then give examples of how modelling can be
useful to answer equity questions, and highlight some of the findings from the
publications that did. Lastly, we describe seven considerations that seem
important to consider when including equity in future vaccine allocation
models.